The company was under Corporate Insolvency Resolution Process ('CIRP') as per the IBC, 2016. Pursuant to the order passed by NCLT, Chennai allotment has been made to SRJR Lifesciences LLP (Promoter). The company has given intimation to BSE and NSE on March 08, 2022 for open market sale and steps to achieve MPS has been initiated.